RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus

Positive clinical data shows improvement in visual function in patients with infantile nystagmus

1

RevitalVision published positive clinical data for its treatment of infantile nystagmus in the British Journal of Ophthalmology.
2

The study presents the first randomized controlled evidence supporting RevitalVision's efficacy in improving visual function.
3

RevitalVision is an FDA-cleared neuroplasticity-based visual training program designed for patients with infantile nystagmus.
4

Infantile nystagmus is a congenital eye movement disorder characterized by involuntary, rhythmic oscillations of the eyes.
5

The findings indicate a significant advancement in treatment options for individuals affected by this condition.